In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2
General Info
Coverage type
Subnational
Time period covered
May, 2020 - August, 2020
Data type
Survey:
Longitudinal
Keywords
Citation
Contributors
Journal
Études Résult
Pages
1-6
Publication year
2020
Suggested citation
Warszawski J, Bajos N, Meyer L, de Lamballerie X, Seng R, Beaumont A, Slama R, Hisbergues M, Rahib D, Lydie N, Legendre B, Barlet M, Rey S, Raynaud P, Leduc A, Costemalle V, Beck F, Legleye S, Castell L, Givord P, Favre-Martinoz C, Paliod N, Sihol J, Sillard P. In May 2020, 4.5% of the population of metropolitan France had developed antibodies against SARS-CoV-2. Études et Résultats. 2020; (1167): 1-6.